1. Marmura
M. J.
Silberstein
S. D.
& Schwedt
T. J. (2015). The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies. Headache: The Journal of Head and Face Pain
55(1)
3–20. (In Table 2
"Triptans
" including sumatriptan
are listed with a Grade A recommendation as effective for acute migraine treatment). https://doi.org/10.1111/head.12499
2. Silberstein
S. D.
Holland
S.
Lipton
R. B.
& Dodick
D. W. (2012). Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology
78(17)
1337–1345. (In Table 2
propranolol and amitriptyline are listed as having Level A evidence for migraine prevention. Gabapentin is mentioned as having inadequate evidence to support its use). https://doi.org/10.1212/WNL.0b013e3182535d20
3. VanderPluym
J. H.
Halker Singh
R. B.
& Urtecho
M. (2021). Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis. JAMA
325(23)
2357–2369. (This meta-analysis confirms that triptans are highly effective for acute migraine treatment
specifically for pain freedom at 2 hours). https://doi.org/10.1001/jama.2021.7939
4. University of California
San Francisco (UCSF) Headache Center. (n.d.). Medications for Migraine and Headache. UCSF Department of Neurology. (This educational resource clearly distinguishes between "Abortive Medications" like triptans and "Preventive Medications" like beta-blockers
antidepressants
and anti-seizure drugs). Retrieved from https://headache.ucsf.edu/medications-migraine-and-headache (Section: "Abortive Medications" and "Preventive Medications").